QualityNet Jira and QualityNet Confluence will be briefly unavailable on Wednesday, July 24, 2024, between 8:00 PM ET and 9:00 PM ET while the team performs an AMI update.  If you have questions or concerns, please reach out to us in Slack at #help-atlassian.

Page tree

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Next »

Matthew Cooper, MD

Medstar Georgetown Transplant Institute

Matthew Cooper is a Professor of Surgery at Georgetown School of Medicine and Director of Kidney and Pancreas Transplantation and Director for Quality at the Medstar Georgetown Transplant Institute (MGTI). After receiving a medical degree from the Georgetown University School of Medicine in 1994, Dr Cooper completed general surgery training at the Medical College of Wisconsin, followed by a fellowship in multi-organ abdominal transplantation in 2002 at the Johns Hopkins Hospital in Baltimore, MD. He joined the transplant faculty at the Johns Hopkins Hospital upon completion of his training and was appointed Surgical Director of Kidney Transplantation and Clinical Research in 2003. Dr. Cooper joined the University of Maryland in 2005, directing the kidney transplant and clinical research program until 2012, following which he assumed his current role in Washington, DC.

Dr. Cooper seeks new opportunities for living donation through innovation and by removing the disincentives for those considering donation while promoting the safety and long-term care of live organ donors. His clinical interests include kidney and pancreas transplantation, particularly the use of marginal organs. He has chaired both a National Kidney Foundation (NKF)–sponsored Task Force to decrease kidney allograft discards and a United Network of Organ Sharing (UNOS)–sponsored System Performance Improvement Committee, which have led to several exciting projects to potentially bring more patients an opportunity for transplantation. Dr. Cooper is involved in several ongoing clinical research projects primarily with an interest in immunosuppression minimization and amelioration of delayed graft function in kidney allografts following ischemic reperfusion injury. He has authored over 220 peer-reviewed manuscripts, 300 abstracts, and 12 book chapters. He is regularly invited to speak on a variety of transplant-related topics both nationally and internationally.

Dr. Cooper is involved in transplantation activities both locally and on a national basis. He is the current UNOS/Organ Procurement Transplant Network (OPTN) President. He is a member of the National and DC Board of Directors for the NKF and a member of NKF’s National Transplant Task Force. He has served as the chairman of the UNOS Living Donor Committee and recently acted as the Councilor for UNOS’ Region 2. He is a current councilor for the American Society of Transplant Surgeons. He is a current board member for the National Kidney Registry, the American Foundation for Donation and Transplantation, the International Pancreas and Islet Cell Transplant Association, and Donate Life America. Dr. Cooper has served as Chair of the American Transplant Congress.


  • No labels